We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+12.63%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$638M
AUM Growth
+$36.1M
Cap. Flow
-$31.1M
Cap. Flow %
-4.87%
Top 10 Hldgs %
67.85%
Holding
37
New
5
Increased
15
Reduced
10
Closed
6

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$14.7M
2
A icon
Agilent Technologies
A
+$14.1M
3
BIIB icon
Biogen
BIIB
+$12.4M
4
PRGO icon
Perrigo
PRGO
+$8.54M
5
SHPG
Shire pic
SHPG
+$5.79M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$23.4M
2
LLY icon
Eli Lilly
LLY
+$16.8M
3
MRK icon
Merck
MRK
+$12.2M
4
BMY icon
Bristol-Myers Squibb
BMY
+$10.8M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.83M

Sector Composition

Rank Sector Weight
1 Healthcare 98.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
1
Abbott
ABT
$175B
$72.1M 11.3%
982,312
-82,250
-8% -$5.4M
BAX icon
2
Baxter International
BAX
$11.7B
$54.4M 8.54%
706,228
-14,830
-2% -$1.1M
BSX icon
3
Boston Scientific
BSX
$65.4B
$53.3M 8.35%
1,383,374
-77,926
-5% -$2.72M
MRK icon
4
Merck
MRK
$315B
$51.9M 8.13%
766,136
-191,558
-20% -$12.2M
BMY icon
5
Bristol-Myers Squibb
BMY
$124B
$44.8M 7.02%
720,880
-181,346
-20% -$10.8M
SHPG
6
DELISTED
Shire pic
SHPG
$37.2M 5.83%
205,256
+33,431
+19% +$5.79M
RVTY icon
7
Revvity
RVTY
$12.3B
$35.9M 5.63%
369,081
+6,125
+2% +$526K
BIO icon
8
Bio-Rad Laboratories Class A
BIO
$8.15B
$30.3M 4.75%
96,697
+10,248
+12% +$3.18M
NUVA
9
DELISTED
NuVasive, Inc.
NUVA
$28.1M 4.4%
395,223
+19,416
+5% +$1.24M
GILD icon
10
Gilead Sciences
GILD
$167B
$25M 3.91%
323,187
+31,587
+11% +$2.39M
ELV icon
11
Elevance Health
ELV
$80.9B
$22.9M 3.59%
83,513
-4,397
-5% -$1.14M
IART icon
12
Integra LifeSciences
IART
$1.5B
$22.3M 3.5%
338,733
+12,074
+4% +$750K
PRGO icon
13
Perrigo
PRGO
$1.48B
$22.2M 3.48%
313,220
+113,780
+57% +$8.54M
A icon
14
Agilent Technologies
A
$37.1B
$15M 2.36%
+213,300
New +$14.1M
INCY icon
15
Incyte
INCY
$23.4B
$14.8M 2.32%
+213,764
New +$14.7M
UHS icon
16
Universal Health Services
UHS
$9.15B
$13.4M 2.1%
105,012
+6,379
+6% +$783K
BIIB icon
17
Biogen
BIIB
$30.4B
$12.7M 1.99%
+36,000
New +$12.4M
PDCO
18
DELISTED
Patterson Companies, Inc.
PDCO
$11.7M 1.83%
477,707
+165,475
+53% +$3.92M
IONS icon
19
Ionis Pharmaceuticals
IONS
$8.99B
$10.4M 1.64%
202,434
-100,806
-33% -$4.74M
LXRX icon
20
Lexicon Pharmaceuticals
LXRX
$1.06B
$9.2M 1.44%
862,602
– –
CAH icon
21
Cardinal Health
CAH
$53.5B
$7.36M 1.15%
136,335
+10,072
+8% +$515K
AZN icon
22
AstraZeneca
AZN
$262B
$7.24M 1.13%
91,453
-308,841
-77% -$23.4M
PTLA
23
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$7.18M 1.13%
269,701
+68,901
+34% +$2.25M
RDY icon
24
Dr. Reddy's Laboratories
RDY
$10.5B
$5.92M 0.93%
+856,095
New +$5.72M
CLVS
25
DELISTED
Clovis Oncology, Inc.
CLVS
$5.45M 0.85%
185,577
+11,685
+7% +$452K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2018 Portfolio in Review

As of Q3 2018, Sector Gamma AS held 37 positions worth $638M, up 6% from $602M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Sector Gamma AS withdrew a net $31.1M in Q3 2018, closing 6 positions and reducing 10 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $9.83M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 98% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Incyte worth $14.8M.

  • Sector Gamma AS's largest Q3 2018 buy was Incyte: 213,764 shares worth $14.8M.
  • Sector Gamma AS added most to Perrigo in Q3 2018, an estimated $8.54M increase.
  • Sector Gamma AS's biggest Q3 2018 reduction was AstraZeneca, cutting an estimated $23.4M.
  • Sector Gamma AS fully exited Regeneron Pharmaceuticals in Q3 2018, selling an estimated $9.83M.
  • Sector Gamma AS's ten largest holdings make up 68% of its $638M portfolio in Q3 2018.
  • Sector Gamma AS opened 5 new positions and closed 6 in Q3 2018.
  • Sector Gamma AS's portfolio value rose 6% quarter-over-quarter to $638M.

Based on Sector Gamma AS's 13F filing for Q3 2018, filed 8 Nov 2018.